Tag: Risk assessment

How to Justify Batch Release Decisions When Deviations Occur

November 26, 2025November 25, 2025 digi

How to Justify Batch Release Decisions When Deviations Occur Step-by-Step Guide to Justifying Batch Release Decisions When Deviations Occur In pharmaceutical manufacturing, GMP expectations for batch release impose rigorous standards to ensure product quality, safety, and efficacy. Despite robust manufacturing controls, deviations from established processes inevitably occur. Deciding whether a batch with deviations can be…

Batch Release

Cross Contamination Risk Assessment: Practical Tools and Examples

November 26, 2025 digi

Cross Contamination Risk Assessment: Practical Tools and Examples Cross Contamination Risk Assessment: Practical Tools and Examples for Pharma Cross contamination prevention in manufacturing is a critical focus area within pharmaceutical Good Manufacturing Practice (GMP). Effective management of cross contamination risks ensures product quality, patient safety, and regulatory compliance. This step-by-step tutorial outlines practical risk assessment…

Cross Contamination Control

Risk Assessment Template for High Potency Product Manufacturing

November 26, 2025November 25, 2025 digi

Risk Assessment Template for High Potency Product Manufacturing Step-by-Step Guide to Implementing GMP Controls for High Potency Products via Effective Risk Assessment Manufacturing high potency pharmaceutical products demands stringent GMP controls for high potency products to ensure product quality, operator safety, and environmental containment. The unique challenges posed by these substances necessitate a robust and…

High Potency Products

SOP for Quality Risk Management in Line with ICH Q9

November 26, 2025November 25, 2025 digi

SOP for Quality Risk Management in Line with ICH Q9 Step-by-Step Tutorial Guide: Developing a Quality Risk Management SOP Aligned with ICH Q9 Effective quality risk management (QRM) is fundamental to maintaining robust pharmaceutical quality systems compliant with regulatory requirements in the US, UK, and EU. This step-by-step tutorial provides a comprehensive guide to drafting…

Risk Management

Managing Extended Hold Times: Risk Assessment and Stability Data

November 25, 2025November 25, 2025 digi

Managing Extended Hold Times: Risk Assessment and Stability Data Effective Management of Extended Hold Times: A Step-by-Step Guide to Risk Assessment and Stability Data for Bulk Products and Intermediates In pharmaceutical manufacturing, managing hold times between processing steps for bulk products and intermediates is a critical aspect to ensure product quality, integrity, and compliance with…

Hold Time for Bulk & Intermediates

Risk Assessment for Rework and Reprocessing Decisions

November 25, 2025November 25, 2025 digi

Risk Assessment for Rework and Reprocessing Decisions: A GMP Step-by-Step Tutorial Step-by-Step Guide to Risk Assessment for Rework and Reprocessing of Batches GMP In pharmaceutical manufacturing, the rework and reprocessing of batches GMP pose significant challenges for both operational excellence and compliance. Manufacturers must conduct thorough risk assessment to ensure patient safety, regulatory conformity, and…

Rework & Reprocessing

Risk Assessment: When Is Dedicated Equipment Required?

November 25, 2025November 24, 2025 digi

Risk Assessment: When Is Dedicated Equipment Required? Risk Assessment Guide for Determining When Dedicated Equipment is Required in Pharmaceutical Manufacturing Implementing GMP requirements for dedicated equipment is a critical consideration for pharmaceutical manufacturers aiming to comply with regulatory expectations while ensuring product quality and patient safety. This step-by-step tutorial provides a practical framework for conducting…

Dedicated Equipment

GMP Training Needs Analysis: Identifying Gaps Before Inspectors Do

November 15, 2025November 14, 2025 digi

GMP Training Needs Analysis: Identifying Gaps Before Inspectors Do Comprehensive Guide to Conducting a Training Needs Analysis GMP for Pharma Professionals Good Manufacturing Practice (GMP) compliance relies heavily on the competency and proficiency of personnel involved in manufacturing, quality control, and related pharmaceutical processes. A robust training needs analysis GMP is critical to identifying gaps…

Training & Professional Development

FDA Data Integrity Inspections: How to Defend Your Controls and Rationale

November 15, 2025November 14, 2025 digi

FDA Data Integrity Inspections: How to Defend Your Controls and Rationale Practical Guide to Meeting FDA Data Integrity Expectations During Inspections Data integrity remains a cornerstone of regulatory compliance within pharmaceutical manufacturing. The FDA data integrity expectations are rigorous and enforcing, particularly when it comes to data integrity and compliance with drug CGMP. Navigating FDA…

FDA Data Integrity Guidance & Expectations

Data Integrity Risk Assessment: Prioritising Where Controls Matter Most

November 15, 2025November 14, 2025 digi

Data Integrity Risk Assessment: Prioritising Where Controls Matter Most Step-By-Step Guide to Conducting a Data Integrity Risk Assessment in Pharmaceutical Environments Within pharmaceutical manufacturing and quality control, maintaining pharma data integrity is paramount to ensuring patient safety, robust regulatory compliance, and product quality. Regulatory agencies including the US Food and Drug Administration (FDA), the European…

Data Integrity Principles in cGMP Environments